Ken Griffin Options Holdings

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
Acelyrin Inc
PUT
$0
17.6K
Q3 2024
Added 39.68%
Achieve Life Sciences Inc
CALL
$0
22.6K
Q3 2024
Reduced 19.57%
Achieve Life Sciences Inc
PUT
$0
3.7K
Q3 2024
Reduced 19.57%
ACIW
Aci Worldwide, Inc.

Technology
CALL
$35,000
700
Q3 2024
Added 2900.0%
ACIW
Aci Worldwide, Inc.

Technology
PUT
$152,000
3K
Q3 2024
Added 2900.0%
ACRS
Aclaris Therapeutics, Inc.

Healthcare
CALL
$3,000
3.5K
Q3 2024
Reduced 69.7%
ACRS
Aclaris Therapeutics, Inc.

Healthcare
PUT
$1,000
1K
Q3 2024
Reduced 69.7%
ACMR
Acm Research, Inc.

Technology
CALL
$3.38 Million
166K
Q3 2024
Added 10.74%
ACMR
Acm Research, Inc.

Technology
PUT
$5.13 Million
253K
Q3 2024
Added 10.74%
Acres Commercial Realty Corp
CALL
$0
4.5K
Q3 2024
Reduced 85.0%
ATNM
Actinium Pharmaceuticals, Inc.

Healthcare
CALL
$122,000
65.2K
Q3 2024
Reduced 30.0%
ATNM
Actinium Pharmaceuticals, Inc.

Healthcare
PUT
$40,000
21.7K
Q3 2024
Reduced 30.0%
AYI
Acuity Brands Inc

Industrials
CALL
$8.02 Million
29.1K
Q3 2024
Reduced 25.11%
AYI
Acuity Brands Inc

Industrials
PUT
$4.85 Million
17.6K
Q3 2024
Reduced 25.11%
ABOS
Acumen Pharmaceuticals, Inc.

Healthcare
CALL
$7,000
2.9K
Q3 2024
Added 52.31%
ABOS
Acumen Pharmaceuticals, Inc.

Healthcare
PUT
$122,000
49.5K
Q3 2024
Added 52.31%
ACXP
Acurx Pharmaceuticals, Inc.

Healthcare
CALL
$17,000
9.2K
Q3 2024
Reduced 46.99%
ACXP
Acurx Pharmaceuticals, Inc.

Healthcare
PUT
$18,000
9.7K
Q3 2024
Reduced 46.99%
GOLF
Acushnet Holdings Corp.

Consumer Cyclical
CALL
$433,000
6.8K
Q3 2024
Added 106.67%
GOLF
Acushnet Holdings Corp.

Consumer Cyclical
PUT
$197,000
3.1K
Q3 2024
Added 106.67%
ACVA
Acv Auctions Inc.

Consumer Cyclical
CALL
$887,000
43.7K
Q3 2024
Reduced 96.2%
ACVA
Acv Auctions Inc.

Consumer Cyclical
PUT
$6,000
300
Q3 2024
Reduced 96.2%
PEO
Adams Natural Resources Fund, Inc.

Financial Services
CALL
$380,000
16.4K
Q3 2024
Reduced 17.17%
AHCO
Adapt Health Corp.

Healthcare
CALL
$3.88 Million
345K
Q3 2024
Added 524.69%
AHCO
Adapt Health Corp.

Healthcare
PUT
$2.24 Million
200K
Q3 2024
Added 524.69%
ADAP
Adaptimmune Therapeutics PLC

Healthcare
CALL
$26,000
28.1K
Q3 2024
Reduced 56.72%
ADAP
Adaptimmune Therapeutics PLC

Healthcare
PUT
$5,000
5.8K
Q3 2024
Reduced 56.72%
ADPT
Adaptive Biotechnologies Corp

Healthcare
CALL
$193,000
37.7K
Q3 2024
Added 90.32%
ADPT
Adaptive Biotechnologies Corp

Healthcare
PUT
$151,000
29.5K
Q3 2024
Added 90.32%
ADCT
Adc Therapeutics Sa

Healthcare
CALL
$28,000
9K
Q3 2024
Added 10.53%
ADCT
Adc Therapeutics Sa

Healthcare
PUT
$99,000
31.5K
Q3 2024
Added 10.53%
ADUS
Addus Home Care Corp

Healthcare
CALL
$2.23 Million
16.8K
Q3 2024
Reduced 22.58%
ADUS
Addus Home Care Corp

Healthcare
PUT
$637,000
4.8K
Q3 2024
Reduced 22.58%
AGRO
Adecoagro S.A.

Consumer Defensive
CALL
$139,000
12.6K
Q3 2024
Added 200.0%
AGRO
Adecoagro S.A.

Consumer Defensive
PUT
$39,000
3.6K
Q3 2024
Added 200.0%
ADEA
Adeia Inc.

Technology
CALL
$247,000
20.8K
Q3 2024
New holding
ADEA
Adeia Inc.

Technology
PUT
$39,000
3.3K
Q3 2024
New holding
ACET
Adicet Bio, Inc.

Healthcare
CALL
$6,000
4.2K
Q3 2024
Reduced 43.22%
ACET
Adicet Bio, Inc.

Healthcare
PUT
$9,000
6.7K
Q3 2024
Reduced 43.22%
ADNT
Adient PLC

Consumer Cyclical
CALL
$133,000
5.9K
Q3 2024
Added 113.6%
ADNT
Adient PLC

Consumer Cyclical
PUT
$602,000
26.7K
Q3 2024
Added 113.6%
ADMA
Adma Biologics, Inc.

Healthcare
CALL
$4.2 Million
210K
Q3 2024
Added 331.25%
ADMA
Adma Biologics, Inc.

Healthcare
PUT
$965,000
48.3K
Q3 2024
Added 331.25%
ADSE
Ads Tec Energy Public LTD CO

Industrials
CALL
$523,000
39.1K
Q3 2024
New holding
ADSE
Ads Tec Energy Public LTD CO

Industrials
PUT
$14,000
1.1K
Q3 2024
New holding
ADT
Adt Inc.

Industrials
CALL
$204,000
28.2K
Q3 2024
Reduced 56.18%
ADT
Adt Inc.

Industrials
PUT
$28,000
3.9K
Q3 2024
Reduced 56.18%
ATGE
Adtalem Global Education Inc.

Consumer Defensive
CALL
$3.31 Million
43.8K
Q3 2024
Reduced 77.27%
ATGE
Adtalem Global Education Inc.

Consumer Defensive
PUT
$113,000
1.5K
Q3 2024
Reduced 77.27%
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio

Summary

  • Portfolio
  • No. of Stocks 16,902
  • Current Value $505 Billion
  • Prior Value $483 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1,111 stocks
  • Additional Purchases 2,227 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2,336 stocks
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email